Evidence map›Paper›PMID 29380422›Full record

ArticleGlia2018

MicroRNA-31 is required for astrocyte specification.

Gordon P Meares, Rajani Rajbhandari, Magda Gerigk, Chih-Liang Tien, Chenbei Chang, Samuel C Fehling, Amber Rowse, Kayln C Mulhern, Sindhu Nair, G Kenneth Gray and 4 more

Abstract read
In one paragraph

Article in Glia, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Host gene and its guest: short story about relation of long-noncodingReports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2023
    Review
  5. Article
  6. Epigenetics in blood-brain barrier disruption.Fluids and barriers of the CNS · 2021
    Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Gordon P MearesDepartments of Microbiology, Immunology and Cell Biology, West Virginia University, Morgantown, West Virginia, 26506.
Rajani RajbhandariDepartments of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama, 35294.
Magda GerigkDepartments of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, Alabama, 35294.
Chih-Liang TienDepartments of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, Alabama, 35294.
Chenbei ChangDepartments of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, Alabama, 35294.
Samuel C FehlingDepartments of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, Alabama, 35294.
Amber RowseDepartments of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, Alabama, 35294.
Kayln C MulhernDepartments of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, Alabama, 35294.
Sindhu NairDepartments of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama, 35294.
G Kenneth GrayDepartments of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, Alabama, 35294.
Nicolas F BerbariDepartments of Biology, Indiana University-Purdue University Indianapolis, Indianapolis, Indiana, 46202.
Markus BredelDepartments of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama, 35294.
Etty N BenvenisteDepartments of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, Alabama, 35294.
Susan E NozellDepartments of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama, 35294.ORCID 0000-0003-2960-4484
University of Alabama at Birmingham · USUniversity of Indianapolis · USWest Virginia University · US

Funding

XRAY CRYSTALLOGRAPHYP30CA013148 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Robert S Welner · 1985 to 2026
$165.9M
Training Program in Brain Tumor BiologyT32NS048039 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BENVENISTE, ETTY N · 2007 to 2017
$2.0M
The Role of CK2 in Glioblastoma DevelopmentR01CA194414 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BENVENISTE, ETTY N · 2016 to 2020
$1.7M
Targeting the JAK/STAT-3 Pathway Signaling Axis in GliomaR01CA158534 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BENVENISTE, ETTY N · 2012 to 2016
$1.5M
Characterizing the Role of NF-kB in Promoting Glioma TumorigenicityR01CA138517 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI NOZELL, SUSAN E · 2010 to 2014
$1.3M
Connecting signaling with cytoskeleton: Abl and Arg in vertebrate gastrulationR01GM098566 · NIGMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CHANG, CHENBEI · 2012 to 2015
$1.3M
NCI NIH HHS P30 CA013148NCI NIH HHS R01 CA138517NCI NIH HHS R01 CA158534NCI NIH HHS R01 CA194414NIGMS NIH HHS R01 GM098566NINDS NIH HHS T32 NS048039
6 · The paper itself

Abstract

Previously, we determined microRNA-31 (miR-31) is a noncoding tumor suppressive gene frequently deleted in glioblastoma (GBM); miR-31 suppresses tumor growth, in part, by limiting the activity of NF-κB. Herein, we expand our previous studies by characterizing the role of miR-31 during neural precursor cell (NPC) to astrocyte differentiation. We demonstrate that miR-31 expression and activity is suppressed in NPCs by stem cell factors such as Lin28, c-Myc, SOX2 and Oct4. However, during astrocytogenesis, miR-31 is induced by STAT3 and SMAD1/5/8, which mediate astrocyte differentiation. We determined miR-31 is required for terminal astrocyte differentiation, and that the loss of miR-31 impairs this process and/or prevents astrocyte maturation. We demonstrate that miR-31 promotes astrocyte development, in part, by reducing the levels of Lin28, a stem cell factor implicated in NPC renewal. These data suggest that miR-31 deletions may disrupt astrocyte development and/or homeostasis.

Indexed as

AnimalsAstrocytesCell DifferentiationCells, CulturedFluorescent Antibody TechniqueImmunoblottingIn Situ HybridizationMice, Inbred C57BLMicroRNAsNeural Stem CellsReal-Time Polymerase Chain ReactionRNA-Binding ProteinsXenopus laevisLin-28 protein, mouseMicroRNAsRNA-Binding ProteinsastrocytesdifferentiationmicroRNA-31neural precursor cell

Identifiers

PMID29380422
PMCPMC5851835
OpenAlexW2790988907

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.